tradingkey.logo

Harvard Bioscience Inc

HBIO
View Detailed Chart

0.436USD

0.0000.00%
Close 08/01, 16:00ETQuotes delayed by 15 min
19.28MMarket Cap
LossP/E TTM

Harvard Bioscience Inc

0.436

0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Today

-6.36%

5 Days

-22.77%

1 Month

-3.73%

6 Months

-73.57%

Year to Date

-79.33%

1 Year

-85.37%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 2 analysts
BUY
Current Rating
3.000
Target Price
587.92%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

95
Total
4
Median
7
Average
Company name
Ratings
Analysts
Harvard Bioscience Inc
HBIO
2
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
34
Veeva Systems Inc
VEEV
32
Thermo Fisher Scientific Inc
TMO
31
1
2
3
...
19

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(8)
Neutral(3)
Buy(0)
Indicators
Sell(2)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.006
Neutral
RSI(14)
43.853
Neutral
STOCH(KDJ)(9,3,3)
13.847
Sell
ATR(14)
0.054
High Vlolatility
CCI(14)
-48.380
Neutral
Williams %R
80.244
Oversold
TRIX(12,20)
0.349
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
0.482
Sell
MA10
0.499
Sell
MA20
0.470
Sell
MA50
0.467
Sell
MA100
0.463
Sell
MA200
1.193
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bioproduction and preclinical testing for pharmaceutical and therapy development. Its products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. The CMT product family is primarily composed of products supporting research related to molecular, cellular, organ and organoid technologies. The Preclinical product family includes products that support the preclinical research and testing phase for drug development, and in particular, testing related to data collection and analysis for safety and regulatory compliance.
Ticker SymbolHBIO
CompanyHarvard Bioscience Inc
CEOMr. John D. Duke
Websitehttps://www.harvardbioscience.com/
KeyAI